INTERACCIONES GEN - AMBIENTE - SALUD
GIIGAS
![Foto de INTERACCIONES GEN - AMBIENTE - SALUD](/img/grupo.png)
![Foto de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas](/img/noimage_org.png)
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (75)
2024
-
Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population
Journal of Endocrinological Investigation, Vol. 47, Núm. 6, pp. 1405-1418
-
Coronavirus disease 2019 is associated with long-term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome
Psychological Medicine, Vol. 54, Núm. 3, pp. 620-630
-
Effect of a nutritional intervention based on an energy-reduced Mediterranean diet on environmental impact
Science of the Total Environment, Vol. 928
-
Impact of mediterranean diet promotion on environmental sustainability: a longitudinal analysis
Public Health, Vol. 230, pp. 12-20
-
Microbial Phenolic Metabolites Are Associated with Improved Cognitive Health
Molecular Nutrition and Food Research, Vol. 68, Núm. 2
-
More Adult Women than Men at High Cardiometabolic Risk Reported Worse Lifestyles and Self-Reported Health Status in the COVID-19 Lockdown
Nutrients, Vol. 16, Núm. 13
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
An Energy-Reduced Mediterranean Diet, Physical Activity, and Body Composition: An Interim Subgroup Analysis of the PREDIMED-Plus Randomized Clinical Trial
JAMA network open, Vol. 6, Núm. 10, pp. e2337994
-
Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort
BMC Medicine, Vol. 21, Núm. 1
-
Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort(Front. Endocrinol., (2022), 13, (868795), 10.3389/fendo.2022.868795)
Frontiers in Endocrinology
-
Increase from low to moderate, but not high, caffeinated coffee consumption is associated with favorable changes in body fat
Clinical Nutrition, Vol. 42, Núm. 4, pp. 477-485
-
Increased ultra-processed food consumption is associated with worsening of cardiometabolic risk factors in adults with metabolic syndrome: Longitudinal analysis from a randomized trial
Atherosclerosis, Vol. 377, pp. 12-23
-
Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial
Journal of Nutrition, Health and Aging, Vol. 27, Núm. 12, pp. 1162-1167
-
Ultra-processed foods consumption as a promoting factor of greenhouse gas emissions, water, energy, and land use: A longitudinal assessment
Science of the Total Environment, Vol. 891
2022
-
Adopting a High-Polyphenolic Diet Is Associated with an Improved Glucose Profile: Prospective Analysis within the PREDIMED-Plus Trial
Antioxidants, Vol. 11, Núm. 2
-
Association Among Polyphenol Intake, Uric Acid, and Hyperuricemia: A CrossSectional Analysis in a Population at High Cardiovascular Risk
Journal of the American Heart Association, Vol. 11, Núm. 20
-
Association between the Prime Diet Quality Score and depressive symptoms in a Mediterranean population with metabolic syndrome. Cross-sectional and 2-year follow-up assessment from PREDIMED-PLUS study
British Journal of Nutrition, Vol. 128, Núm. 6, pp. 1170-1179
-
Associations Between the Modified Food Standard Agency Nutrient Profiling System Dietary Index and Cardiovascular Risk Factors in an Elderly Population
Frontiers in Nutrition, Vol. 9
-
Circulating carotenoids are associated with favorable lipid and fatty acid profiles in an older population at high cardiovascular risk
Frontiers in Nutrition, Vol. 9
-
Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study
PLoS ONE, Vol. 17, Núm. 4 April